| Cancer statistics, 2008 | Ca-A Cancer Journal for Clinicians | 2008 | 8.9K |
| One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States | Journal of Clinical Oncology | 2008 | 3.1K |
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Nature Reviews Cancer | 2008 | 2.7K |
| Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer | Journal of Clinical Oncology | 2008 | 2.7K |
| Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer | Journal of Clinical Oncology | 2008 | 2.6K |
| Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study | Journal of Clinical Oncology | 2008 | 2.3K |
| Modes of resistance to anti-angiogenic therapy | Nature Reviews Cancer | 2008 | 2.3K |
| Therapeutic nanoparticles for drug delivery in cancer | Clinical Cancer Research | 2008 | 2.2K |
| Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial | Journal of the National Cancer Institute | 2008 | 2K |
| Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome | Cell Host and Microbe | 2008 | 2K |
| Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer | Journal of Clinical Oncology | 2008 | 1.9K |
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Gynecologic Oncology | 2008 | 1.9K |
| Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study | Lancet Oncology, The | 2008 | 1.7K |
| Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer | Clinical Cancer Research | 2008 | 1.7K |
| Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group | Journal of Clinical Oncology | 2008 | 1.7K |
| Tumor cell metabolism: cancer's Achilles' heel | Cancer Cell | 2008 | 1.6K |
| Insulin and insulin-like growth factor signalling in neoplasia | Nature Reviews Cancer | 2008 | 1.5K |
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Oncogene | 2008 | 1.5K |
| Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group | Journal of Clinical Oncology | 2008 | 1.5K |
| The interleukin-8 pathway in cancer | Clinical Cancer Research | 2008 | 1.5K |
| S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial | Lancet Oncology, The | 2008 | 1.4K |
| PI3K pathway alterations in cancer: variations on a theme | Oncogene | 2008 | 1.4K |
| Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy | Journal of the National Cancer Institute | 2008 | 1.4K |
| Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer | Journal of Clinical Oncology | 2008 | 1.4K |
| International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes | Journal of Clinical Oncology | 2008 | 1.4K |
